logo

For the Inventor, By the Inventor

Wuppertal, Germany

Frank Süβmeier

This inventor holds 16 USPTO granted patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Süβmeier. Retrieved from https://idiyas.com/inventor/frank-süβmeier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 18.8

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Wuppertal, DE (2010 - 2014)
  • München, DE (2014 - 2017)
  • Munich, DE (2014 - 2019)

Company Filing History:

goldMedal9 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
silverMedal4 out of 386 
 
Bayer Pharma Aktiengesellschaft
 patents
bronzeMedal4 out of 192 
 
Bayer Schering Pharma Ag
 patents
where one patent can have more than one assignee

Years Active: 2010-2019

Loading Chart...
16 patents (USPTO):Explore Patents
1. 10428083 - Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor (2019-10-01),
2. 9771352 - Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof (2017-09-26),
3. 9604996 - Cyclic thienouracil-carboxamides and use thereof (2017-03-28),
4. 9394309 - Substituted phenylimidazopyrazoles and their use (2016-07-19),
5. 9205077 - 2-alkoxy-substituted dicyanopyridines and their use (2015-12-08),
6. 9040691 - Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors (2015-05-26),
7. 8791146 - 2-alkoxy-substituted dicyanopyridines and their use (2014-07-29),
8. 8772498 - Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof (2014-07-08),
9. 8703934 - Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof (2014-04-22),
10. 8618119 - Fused cyanopyridines and the use thereof (2013-12-31),
11. 8609686 - Substituted azabicyclic compounds and the use thereof (2013-12-17),
12. 8426602 - Heteroaryl-substituted dicyanopyridines and their use (2013-04-23),
13. 7960387 - 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses (2011-06-14),
14. 7776922 - Substituted [(phenylethanoyl)amino]benzamides (2010-08-17),
15. 7709491 - Substituted quinazolines as antiviral agents, especially against cytomegaloviruses (2010-05-04),

Title: Frank Süßmeier: Innovator in Pharmaceutical Chemistry

Introduction

Frank Süßmeier is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 16 patents. His work primarily focuses on developing novel compounds for the treatment and prevention of various diseases.

Latest Patents

One of his latest patents is titled "Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor." This application relates to innovative thieno[2,3-d]pyrimidine-2,4-dione derivatives that possess a specific type of (azaheterocyclyl)methyl substituent. The patent outlines processes for preparing these compounds and their potential use in treating pulmonary and cardiovascular disorders, as well as cancer. Another significant patent is "Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof." This invention involves novel 5-(hydroxyalkyl)-1-phenyl-1,2,4-triazole derivatives, detailing their preparation, pharmaceutical compositions, and applications in treating cardiovascular and renal diseases.

Career Highlights

Throughout his career, Frank Süßmeier has worked with prominent companies such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Frank has collaborated with notable professionals in his field, including Peter Nell and Alexandros Vakalopoulos. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Frank Süßmeier is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…